The new facility is located at its Braine-l’Alleud site and will employ 100 employees. This new facility will produce cell culture-based therapeutic proteins that are dedicated to accelerating the availability of new drugs for severe diseases with a focus on the research and clinical trial phases
This new facility is designed enable UCB to improve its biological medicines.
Chief executive Roch Doliveux said that “today, 33% of drugs for human use worldwide are of biotechnological origin and represent more than half of UCB’s current R&D pipeline”. He added that “with this bio pilot plant, we will more rapidly initiate clinical studies of new antibody-based therapeutics”.
Are you looking for a new science based role?
Tags: Belgium, Biotech, biotechnology facility, chemicals, CK Science, Clinical jobs, engineering jobs, graduate science jobs uk, jobs in science, lab staff, medical devices, new biotechnology, Pharmaceutical, PharmaTimes, recruitment agencies, science, science employment, science engineering jobs, science jobs, science jobs uk, science recruitment, scientific job agencies, scientific jobs, scientific recruiting, scientific recruitment agencies uk, scientific recruitment uk, ucb